Skip to Content

Notice

Importer of Controlled Substances Application: Research Triangle Institute

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

ACTION:

Notice of application.

DATES:

Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.34(a) on or before September 3, 2015. Such persons may also file a written request for a hearing on the application pursuant to 21 CFR 1301.43 on or before September 3, 2015.

ADDRESSES:

Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/ODXL, 8701 Morrissette Drive, Springfield, Virginia 22152. Request for hearings should be sent to: Drug Enforcement Administration, Attention: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152. Comments and requests for hearings on applications to import narcotic raw material are not appropriate. 72 FR 3417 (January 25, 2007).

End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Deputy Assistant Administrator of the DEA Office of Diversion Control (“Deputy Assistant Administrator”) pursuant to section 7 of 28 CFR part 0, appendix to subpart R.

In accordance with 21 CFR 1301.34(a), this is notice that on March 12, 2015, Research Triangle Institute, Kenneth S. Rehder, Hermann Building East Institute Drive, P.O. Box 12194, Research Triangle Park, North Carolina 27709-2194 applied to be registered as an importer of the following basic classes of controlled substances:

Controlled substanceSchedule
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1-1H-indazole-3-carboxamide) (7023)I
AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (7031)I
AM-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indole) (7201)I
AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) (7694)I
JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl) indole) (7118)I
JWH-073 (1-Butyl-3-(1-naphthoyl)indole) (7173)I
Start Printed Page 46331
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) (7200)I
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) (6250)I
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) (7019)I
JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) (7081)I
JWH-122 (-Pentyl-3-(4-methyl-1-naphthoyl) indole) (7122)I
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) (7203)I
JWH-398 (1-Pentyl-3-(4-chloro-1-naphththoyl) indole) (7398)I
THJ-2201 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalene-1-yl)methanone (7024)I
1-(1-Phenylcyclohexyl)pyrrolidine (7458)I
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470)I
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine (7473)I
1-Methyl-4-phenyl-4-propionoxypiperidine (9661)I
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine (9663)I
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) (7348)I
2,5-Dimethoxy-4-ethylamphetamine (7399)I
2,5-Dimethoxyamphetamine (7396)I
2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D) (7508)I
2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E) (7509)I
2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) (7517)I
2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N) (7521)I
2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C-P) (7524)I
2-(4-isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C-T-4) (7532)I
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe) (7536)I
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) (7348)I
2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T-2) (7385)I
2-(4-Lodo-2,5-dimethoxyphenyl) ethanamine (2C-I) (7518)I
2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C) (7519)I
3,4,5-Trimethoxyamphetamine (7390)I
3,4-Methylenedioxyamphetamine (7400)I
3,4-Methylenedioxy-N-ethylamphetamine (7404)I
3,4-Methylenedioxymethamphetamine (7405)I
3-Methylfentanyl (9813)I
3-Methylthiofentanyl (9833)I
4-Bromo-2,5-dimethoxyamphetamine (7391)I
4-Bromo-2,5-dimethoxyphenethylamine (7392)I
4-Methyl-2,5-dimethoxyamphetamine (7395)I
4-Methylaminorex (cis isomer) (1590)I
4-Methoxyamphetamine (7411)I
5-Methoxy-3,4-methylenedioxyamphetamine (7401)I
5-Methoxy-N,N-dimethyltryptamine (7431)I
5-Methoxy-N,N-diisopropyltryptamine (7439)I
Acetorphine (9319)I
Acetyl-alpha-methylfentanyl (9815)I
Acetyldihydrocodeine (9051)I
Acetylmethadol (9601)I
Allylprodine (9602)I
Alpha-ethyltryptamine (7249)I
Alpha-methylfentanyl (9814)I
Alpha-methylthiofentanyl (9832)I
Alpha-methyltryptamine (7432)I
Alphacetylmethadol except levo-alphacetylmethadol (9603)I
Alphameprodine (9604)I
Alphamethadol (9605)I
Aminorex (1585)I
Benzethidine (9606)I
Benzylmorphine (9052)I
Beta-hydroxy-3-methylfentanyl (9831)I
Beta-hydroxyfentanyl (9830)I
Betacetylmethadol (9607)I
Betameprodine (9608)I
Betamethadol (9609)I
Betaprodine (9611)I
Bufotenine (7433)I
CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) (7297)I
CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) (7298)I
Cathinone (1235)I
Clonitazene (9612)I
Codeine methylbromide (9070)I
Codeine-N-oxide (9053)I
Cyprenorphine (9054)I
Desomorphine (9055)I
Dextromoramide (9613)I
Diampromide (9615)I
Diethylthiambutene (9616)I
Start Printed Page 46332
Diethyltryptamine (7434)I
Difenoxin (9168)I
Dihydromorphine (9145)I
Dimenoxadol (9617)I
Dimepheptanol (9618)I
Dimethylthiambutene (9619)I
Dimethyltryptamine (7435)I
Dioxaphetyl butyrate (9621)I
Dipipanone (9622)I
Drotebanol (9335)I
Ethylmethylthiambutene (9623)I
Etonitazene (9624)I
Etorphine (except HCl) (9056)I
Etoxeridine (9625)I
Fenethylline (1503)I
Furethidine (9626)I
Gamma Hydroxybutyric Acid (2010)I
Heroin (9200)I
Hydromorphinol (9301)I
Hydroxypethidine (9627)I
Ibogaine (7260)I
Ketobemidone (9628)I
Levomoramide (9629)I
Levophenacylmorphan (9631)I
Lysergic acid diethylamide (7315)I
MDPV (3,4-Methylenedioxypyrovalerone) (7535)I
Marihuana (7360)I
Mecloqualone (2572)I
Mephedrone (1248)I
Mescaline (7381)I
Methaqualone (2565)I
Methcathinone (1237)I
Methyldesorphine (9302)I
Methyldihydromorphine (9304)I
Methylone (3,4-Methylenedioxy-N-methylcathinone) (7540)I
Morpheridine (9632)I
Morphine methylbromide (9305)I
Morphine methylsulfonate (9306)I
Morphine-N-Oxide (9307)I
Myrophine (9308)I
N,N-Dimethylamphetamine (1480)I
N-Benzylpiperazine (7493)I
N-Ethyl-3-piperidyl benzilate (7482)I
N-Ethylamphetamine (1475) N-Ethyl-1-phenylcyclohexylamine (7455)I
N-Hydroxy-3,4-methylenedioxyamphetamine (7402)I
Nicocodeine (9309)I
Nicomorphine (9312)I
N-Methyl-3-piperidyl benzilate (7484)I
Noracymethadol (9633)I
Norlevorphanol (9634)I
Normethadone (9635)I
Normorphine (9313)I
Norpipanone (9636)I
Para-Fluorofentanyl (9812)I
Parahexyl (7374)I
Peyote (7415)I
Phenadoxone (9637)I
Phenampromide (9638)I
Phenomorphan (9647)I
Phenoperidine (9641)I
Pholcodine (9314)I
Piritramide (9642)I
Proheptazine (9643)I
Properidine (9644)I
Propiram (9649)I
Psilocybin (7437)I
Psilocyn (7438)I
Racemoramide (9645)I
SR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) (7008)I
SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole (7104)I
Tetrahydrocannabinols (7370)I
Thebacon (9315)I
Thiofentanyl (9835)I
Tilidine (9750)I
Start Printed Page 46333
Trimeperidine (9646)I
1-Phenylcyclohexylamine (7460)II
1-Piperidinocyclohexanecarbonitrile (8603)II
4-Anilino-N-phenethyl-4-piperidine (ANPP) (8333)II
Alfentanil (9737)II
Alphaprodine (9010)II
Amobarbital (2125)II
Amphetamine (1100)II
Anileridine (9020)II
Bezitramide (9800)II
Carfentanil (9743)II
Coca Leaves (9040)II
Cocaine (9041)II
Codeine (9050)II
Dextropropoxyphene, bulk (non-dosage forms) (9273)II
Dihydrocodeine (9120)II
Dihydroetorphine (9334)II
Diphenoxylate (9170)II
Ecgonine (9180)II
Ethylmorphine (9190)II
Etorphine HCl (9059)II
Fentanyl (9801)II
Glutethimide (2550)II
Hydrocodone (9193)II
Hydromorphone (9150)II
Isomethadone (9226)II
Levo-alphacetylmethadol (9648)II
Levomethorphan (9210)II
Levorphanol (9220)II
Lisdexamfetamine (1205)II
Meperidine (9230)II
Meperidine intermediate-A (9232)II
Meperidine intermediate-B (9233)II
Meperidine intermediate-C (9234)II
Metazocine (9240)II
Methadone (9250)II
Methadone intermediate (9254)II
Methamphetamine (1105)II
Methylphenidate (1724)II
Metopon (9260)II
Moramide-intermediate (9802)II
Morphine (9300)II
Nabilone (7379)II
Opium, raw (9600)II
Opium extracts (9610)II
Opium fluid extract (9620)II
Opium tincture (9630)II
Opium powdered (9639)II
Opium poppy/Poppy Straw (9650)II
Oripavine (9330)II
Poppy Straw Concentrate (9670)II
Opium, granulated (9640)II
Oxycodone (9143)II
Oxymorphone (9652)II
Pentobarbital (2270)II
Phenazocine (9715)II
Phencyclidine (7471)II
Phenmetrazine (1631)II
Phenylacetone (8501)II
Piminodine (9730)II
Racemethorphan (9732)II
Racemorphan (9733)II
Remifentanil (9739)II
Secobarbital (2315)II
Sufentanil (9740)II
Tapentadol (9780)II
Thebaine (9333)II

The company plans to import small quantities of the listed controlled substances for the National Institute on Drug Abuse (NIDA) for research activities.

The company plans to import analytical reference standards for distribution to its customers for research Start Printed Page 46334and analytical purposes. Placement of these drug codes onto the company's registration does not translate into automatic approval of subsequent permit applications to import controlled substances. Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized under to 21 U.S.C. 952(a)(2). Authorization will not extend to the import of FDA approved or non-approved finished dosage forms for commercial sale.

Start Signature

Dated: July 29, 2015.

Joseph T. Rannazzisi,

Deputy Assistant Administrator.

End Signature End Supplemental Information

[FR Doc. 2015-19158 Filed 8-3-15; 8:45 am]

BILLING CODE 4410-09-P